Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
marketbeat.comSensus Healthcare Q1 Earnings Call Highlightsmarketbeat.comMay 8
businesswire.comSensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncologybusinesswire.comMay 8
seekingalpha.comSensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 8
businesswire.comSensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlightsbusinesswire.comMay 7
businesswire.comSensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026businesswire.comApr 23